Loss-making quarter, cost guidance missed, recovery unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade C
Q2 cost guidance badly missed (₹260/ton actual vs ₹70-80 guided). Maintained capex/capacity targets despite weak execution. Jaypee integration timeline unchanged but not yet demonstrated.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Loss-making quarter with cost guidance missed by 3x (₹260/ton vs ₹70-80 guided) masks structural margin compression despite 4.3% revenue growth. Capacity expansion on track, but near-term utilization at 35%-40% and Jaypee integration to normal margins will take 7-8 quarters, creating a prolonged drag. Recovery path articulated for Q3 but unproven.
₹3563 Cr
Revenue · +4.3% YoY₹-205 Cr
Reported PAT · −185.8% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Volumes grew 4% YoY on ex-Central basis
METVolumes rose 3% to 7.1 MT in quarter, 4% YoY ex-Central confirmed
Q2 cost headwinds ₹70-80/ton (prior guidance)
MISSTotal cost increased by roughly INR260/ton on ex-Central basis, INR200 variable + INR100 fuel + INR30-40 materials
Belgaum clinker line ahead of schedule, trial runs imminent
METBelgaum clinker line trial initiated ahead of schedule, cement mill trial expected in couple weeks
Jaypee EBITDA neutral in couple quarters, 7-8 quarters to normal Dalmia margins
METQ3 dilution INR100-125/ton expected, targeting breakeven by Q4 FY27, no change to 7-8 quarter normalization timeline
35%-40% capacity utilization target on new assets by end of FY27
METManagement stated 35%-40% utilization by end of FY27 as aspiration, unverified
Earnings quality
What changed since the last call
CMO transition announced
NewNavin Tewari (former multi-industry executive) becomes key adviser effective Jan 1, 2027. Yatin Malhotra adds sales/marketing responsibility. Strategic but execution risk on transition.
Konark brand phased out
DowngradePremium portfolio reshuffled; Konark (cornerstone brand for decades) exiting to sharpen Dalmia focus. ₹60 Cr write-off taken. Strategic shift, not margin recovery.
Capex maintained, not cut
NeutralINR3,200 Cr capex unchanged despite Q2 miss. Management signaling commitment to expansion despite weak near-term ROIC. Jaypee to be commercialized Q4.
The Q&A
Analysts pressed hard on capacity utilization (60-65% vs peers >70%), cost control (missed Q2 forecast by 3x), and Jaypee execution timeline. Management defended with one-off framing and deferred specificity ('too early to comment'). Tone: defensive, not evasive entirely but cautious.
EBITDA per ton performance — Prateek Kumar, Jefferies India
AnsweredRegional mix (East/Northeast subdued), fixed cost absorption from low volumes, cost inflation INR260/ton. Expecting better H2. One-off items inflated loss.
Jaypee capacity, dilution timeline — Amit Murarka, Axis Capital
PartialQ3 dilution INR100-125/ton as Jaypee ramps. 35%-40% utilization target by Q4, scaling to normal Dalmia margins over 7-8 quarters. Breakeven by Q4 FY27. No volume sold yet.
Fuel and cost inflation persistence — Prateek Kumar, Jefferies India
PartialCurrently INR75-80 at INR180/bbl crude. Could see INR75/ton in Q3, but expecting price increase recovery (INR15/kg already seen in October). Too early to commit Q4.
Central India asset ramp and strategy — Indrajit Agarwal, CLSA India
PartialCapacity sufficient for expansion. Selling through trade and non-trade. All capex investments will be capitalized; volume ramp pending. No specific capex backlog disclosed.
Volume growth expectation for H2 — Rahul Gupta, Morgan Stanley
DodgedEast/Northeast impacted by monsoons this quarter, heavy rainfall. Should improve seasonally. Not giving micro guidance by region. Industry growth our baseline.
Belgaum and Pune timeline — Siddharth Mehrotra, Kotak Securities
PartialWill touch 67 MT with all three (Central, Belgaum, Kadapa). BJCL would push to ~70. 75 MT was historical aspiration. ₹10,000 Cr capex broadly needed. One by one, clinker and mill commissioning will happen.
Leadership transition rationale — Satyadeep Jain, AMBIT Capital
AnsweredPlanned transition. Navin to advise on strategic initiatives. Yatin (CFO) takes additional sales/marketing responsibility. Multi-industry experience from consumer sector. Continuity and deep Dalmia knowledge retained.
Capacity utilization and future ramp — Girija Ray, Nirmal Bang
DodgedCurrently 60-65%, between peers. Infrastructure demand strong. Won't comment micro-market by micro-market. All capex will be utilized market by market. Learnings ahead in execution, but long-term story intact.
Guidance
FY27 capex ₹3,200 Cr (maintained, ex-Jaypee deal)
HighOrganic capex on track. Belgaum, Pune, Kadapa progressing as planned. Jaypee capex separate accounting.
Q3 cost impact INR100-125/ton benefit (mix + volume + pricing)
MediumAssumes demand recovery in East/Northeast, pricing pass-through INR15/kg continues, fixed cost leverage from volume ramp. Unproven.
Jaypee breakeven by Q4 FY27, 7-8 quarters to normal Dalmia margins
LowJaypee currently diluting, 7-8 quarters is a long integration tail. Cost to restart and ramp unknown; mine risk unresolved.
FY27 capex ₹3,200 Cr (unchanged); capacity 67 MT by Q3 FY28, target 70 MT with Northeast
MediumProjects on track but near-term utilization 35%-40%. Capex not derailing despite weak ROIC; management signaling conviction to scale.
Risks the call surfaced
Margin compression
HighQ2 cost headwinds (₹260/ton vs ₹70-80 guided) 3x worse than expected. Jaypee dilution INR100-125/ton for multiple quarters. If recovery (INR100-125 benefit Q3) fails to materialize, NPM remains negative-to-minimal.
Capacity utilization
HighBelgaum, Pune, Kadapa, Central all at 35%-40% utilization by Q4 FY27. If volume ramp slows or regional demand (East/Northeast) remains weak, stranded capex and margin dilution compound. Fixed cost absorption risk.
Jaypee integration
HighJaypee expected to dilute for 7-8 quarters before reaching Dalmia normal margins. Capex ₹2,850 Cr to date (including ₹300 Cr refurbishment). Mining rights valuation still uncertain (PPA finalizing over 1-year window). MMDR Act amendment (mineral land tax discontinuation Aug 22) helped liabilities but mine compliance risk persists.
Regional demand weakness
MediumEast and Northeast suffered severe monsoons; prices under pressure. Dalmia's East volumes subdued, pricing down ~1% Q-o-Q. Incentives used (INR25 Cr) signal market share pressure. Dalmia's growth behind regional peers (some at >70% market share East vs Dalmia position unclear).
Execution and brand risk
MediumKonark brand (decades-old cornerstone) being phased out; ₹60 Cr write-off taken. CMO transition (Navin Tewari stepped down, Yatin takes additional marketing role) is a significant shift. Premiumization strategy unproven vs market acceptance. Execution risk on brand repositioning.
Management
Score 6/10. Good on cost breakdown and project status (detailed on capex, utilization targets). Defensive on regional capacity ('we stick to that story'). Evasive on specifics when pressed (market share by region, FY28 capacity utilization outlook). 'Too early to comment' used frequently. Q2 cost guidance missed by 3x (₹70-80 guided vs ₹260 actual). Capex and capacity targets unchanged despite weak delivery. Jaypee integration on track but payback uncertain (7-8 quarters is long). Fixed cost absorption and one-offs masked underlying margin pressure.
1 · Q3 FY27
Belgaum clinker line trial run, cement mill trial, pricing recovery INR15/kg
2 · Q4 FY27
Jaypee expected to reach breakeven, Pune/Kadapa ramp-up ongoing
3 · FY28
70 MT capacity target with Northeast grinding online, 75 MT aspirational
Recovery path articulated for Q3 but unproven.
Informational and educational content only. Not investment advice.